LINC00304: A Potential Drug Target for Cancer (G283860)

Target Name: LINC00304

NCBI ID: G283860

LINC00304

Other Name(s): NCRNA00304 | Long intergenic non-protein coding RNA 304 | C16orf81 | long intergenic non-protein coding RNA 304

LINC00304: A Potential Drug Target for Cancer

LINC00304 is a non-coding RNA molecule that has been identified as a potential drug target (or biomarker) for the treatment of various diseases, including cancer. Its unique structure and function have made it an attractive target for researchers to study and develop new treatments.

LINC00304 is a long non-coding RNA molecule that is approximately 200 nucleotides in length. It is expressed in a variety of tissues and cells in the body, including the brain, heart, liver, and pancreas. It is also highly expressed in cancer tissues, which makes it an attractive target for cancer treatments.

One of the key features of LINC00304 is its ability to interact with other molecules and proteins in the body. It has been shown to interact with a variety of proteins, including the protein known as NF-kappa-B. NF-kappa-B is a transcription factor that is involved in a wide range of cellular processes, including cell signaling and inflammation. LINC00304 has been shown to play a role in regulating the activity of NF-kappa-B, which suggests that it may be a useful target for cancer treatments.

Another potential mechanism by which LINC00304 may be involved in the development and progression of cancer is its role in the regulation of cell apoptosis, or self-destruction. LINC00304 has been shown to be involved in the regulation of cell apoptosis in various tissues and cells in the body, including cancer cells. This suggests that it may be an attractive target for cancer treatments that target this process.

In addition to its potential role in cell apoptosis, LINC00304 has also been shown to be involved in the regulation of cell proliferation. It has been shown to play a role in the regulation of cell proliferation in various tissues and cells in the body, including cancer cells. This suggests that it may be an attractive target for cancer treatments that target this process.

The unique structure and function of LINC00304 have made it an attractive target for researchers to study and develop new treatments. Its ability to interact with other molecules and proteins in the body and its role in the regulation of cell apoptosis and proliferation make it a promising target for cancer treatments. Further research is needed to fully understand the role of LINC00304 in the development and progression of cancer, as well as its potential as a drug target.

Protein Name: Long Intergenic Non-protein Coding RNA 304

The "LINC00304 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00304 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets